Lexington Partners’s Medline MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-134,232
Closed -$5.97M – 3
2026
Q1
$5.97M Hold
134,232
– – 1.63% 2
2025
Q4
$5.64M Buy
+134,232
New +$5.67M 1.66% 3

Other funds holding MDLN

Lexington Partners's MDLN Position: Q2 2026 in Review

Lexington Partners sold out of Medline (MDLN) in Q2 2026, closing a stake of 134,232 shares — an estimated $5.97M sold.

Lexington Partners first reported a position in MDLN in Q4 2025 and held it in 2 quarters. The position peaked at $5.97M in Q1 2026. 413 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Lexington Partners reported no remaining Medline position as of Q2 2026 after selling out during the quarter.
  • Lexington Partners sold 134,232 Medline shares in Q2 2026, an estimated $5.97M.
  • Lexington Partners first reported a position in Medline in Q4 2025 and held it in 2 quarters.
  • Lexington Partners's Medline position peaked at $5.97M in Q1 2026.
  • 413 funds tracked by Wall St. Rank held Medline as of Q2 2026.

Based on Lexington Partners's 13F filing for Q2 2026, filed 7 Aug 2026.